← Evidence map

ArticleThe Lancet. Neurology2014

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply.

Steven M Greenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2014

2015

2016

2017

2018

2019

2020

this papercites it

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply. | OpenQuestion